Brooklyn Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Brooklyn Investment Group's PFE Position: Q1 2026 in Review
Brooklyn Investment Group increased its Pfizer (PFE) stake by 51% in Q1 2026, buying an estimated $1.22M and bringing the position to 135,740 shares worth $3.81M. The position accounts for 0.12% of the portfolio, ranked #133.
Brooklyn Investment Group first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Brooklyn Investment Group held 135,740 shares of Pfizer worth $3.81M as of Q1 2026.
- Brooklyn Investment Group bought 45,677 Pfizer shares in Q1 2026, an estimated $1.22M.
- Pfizer made up 0.12% of Brooklyn Investment Group's portfolio in Q1 2026, its #133 holding.
- Brooklyn Investment Group first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.